Evolus Rolls Out Estyme HA Fillers Across European Markets
Evolus confirmed plans to bring its Estyme hyaluronic acid injectable filler line to Europe, marking the company's first dermal filler offering beyond its established neurotoxin portfolio.
Topic
Topic
Evolus confirmed plans to bring its Estyme hyaluronic acid injectable filler line to Europe, marking the company's first dermal filler offering beyond its established neurotoxin portfolio.